Tuesday, May 28, 2019 10:26:11 PM
Strong Buy
Recent HROW News
- Harrow Provides TRIESENCE® Relaunch Update • Business Wire • 06/20/2024 11:00:00 AM
- Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery • Business Wire • 06/06/2024 12:00:00 PM
- Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study • Business Wire • 06/05/2024 11:00:00 AM
- Harrow to Present at Two Investor Conferences in May • Business Wire • 05/15/2024 11:00:00 AM
- Harrow Announces First Quarter 2024 Financial Results • Business Wire • 05/13/2024 08:01:00 PM
- Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial • Business Wire • 05/13/2024 11:00:00 AM
- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024 • Business Wire • 04/25/2024 11:00:00 AM
- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing • Business Wire • 04/02/2024 12:16:00 PM
- JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News • IH Market News • 03/20/2024 11:15:48 AM
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results • Business Wire • 03/19/2024 09:45:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:06:28 AM
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024 • Business Wire • 03/05/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:30:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:29:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:33 PM
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products • Business Wire • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:30:18 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/29/2024 08:26:29 PM
- Harrow Announces New Appointments to its Board of Directors • Business Wire • 01/29/2024 12:00:00 PM
- Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease • Business Wire • 01/11/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/09/2024 03:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:00:37 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM